Patients with ≥ 20 × 10(9)/l platelets at baseline may have a prompt response to romiplostim during the early phase of treatment: an italian single-institution experience. [electronic resource]
- Mediterranean journal of hematology and infectious diseases 2012
- e2012044 p. digital